You’re invited to this special event!
Date: October 6, 2021
Time: 8:00 PM ET
Guest Speaker: Dr. Kevin Grove
My Weight – What To Know is featuring a special event on the future of obesity treatments, looking at the research happening now and into the future. This event is only open to those physicians on the My Weight – What To Know clinic locator.
Join us Wednesday, October 6th at 8 pm ET by registering here! At this special event, Dr. Kevin Grove, head of Novo Nordisk’s research lab in Seattle, will share what he and his team are working on, as well as where the research and development in obesity is progressing over the next 5 to 10 years (and he’ll be answering your questions!).
Ansley Dalbo, founder of My Weight – What To Know, will discuss how people living with obesity in Canada are being navigated to the locator to find a physician near them. She’ll present the variety of initiatives being utilized to direct people to the locator, the number of locator visitors so far in 2021 and the demographics of those visitors.
You will also have an opportunity to provide feedback on the locator through chat and polling, as well as interact with your peers in an informal networking session after the event.
Dr. Kevin Grove, PhD
Scientific Vice President, Global Obesity and Liver Disease Research at Novo Nordisk
Dr. Grove is a renowned academic and industry scientist with a relentless drive to understand the biology of obesity, and associated metabolic complications, to find new treatment for patients living with this complex disease. Dr. Grove is currently the Scientific Vice President within the Global Obesity and Liver Disease area and responsible for the early discovery programs at Novo Nordisk’s research center in Seattle, Washington, USA. Since joining Novo Nordisk in September 2014, Dr. Grove has built an exceptional team of scientists from around the world, with biological expertise in brain, muscle, liver and adipose tissues. This highly talented team researches the biologic underpinnings of obesity and liver disease, to discover new biological entities and mechanisms to control appetite and increase metabolism.
The Seattle obesity team partners with other global Novo Nordisk research sites, and with academic and biotech organizations via formal research collaborations. to advance understanding of the disease. In 2017, Dr. Grove was made the Scientific VP for the Obesity Therapy Area and in 2021 this was expanded to include liver disease.
Kevin Grove spent 20 plus years as an academic scientist at Oregon Health Sciences University focusing on pregnancy health and nutrition and the impacts on fetal growth and development. Dr. Grove also led a program focused on progressive pathogenesis of adult onset obesity, with a special focus on developing treatments and interventions for this chronic disease. Prior to that, Dr. Grove received his Ph.D. in Neuroscience and Pharmacology at Washington State University, and completed a postdoctoral fellowship in the Clinical Research Institute of Montreal. He went to Oregon Health & Science University and the Oregon National Primate Research Center in 1996 as a Staff Scientist and moved up the ranks to finally become a Division Chief of the Division of Diabetes, Obesity, & Metabolism at ONPRC.